Product
Dosage Adjustment Rules for Augmented Renal Clearance (DAR-ARC) for Piperacillin-Tazobactam and Meropenem
1 clinical trial
1 indication
Indication
Febrile NeutropeniaClinical trial
Upwards Initial Adjustment of Wide-Spectrum Antibiotic Dosage in Pediatric Oncology Patients With Febrile Neutropenia and Suspected Augmented Renal Clearance: A Randomized Controlled Trial With Therapeutic Drug MonitoringStatus: Not yet recruiting, Estimated PCD: 2026-03-01